drugset / Trial / NCT02513303

Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes

NCT02513303

Phase 3 Completed 269 enrolled Vascular Therapies, Inc.
RandomizedParallel-groupTriple-blindPrevention

Summary

The objective of this study is to evaluate efficacy and safety outcomes following use of the Sirolimus-eluting Collagen Implant (SeCI) in subjects undergoing surgical creation of an AV fistula for vascular access (index procedure).

Timeline

Start
2015-11
Primary completion
2021-06
Completion
2021-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Sirolimus Small molecule